It is a chemicals and materials private limited company based in Serilingampally, Telangana, India, established in 2021.
2021 | Serilingampally, Telangana, India | ActiveSahithi Pharma Private Limited, a active private limited company, was established on 11 May 2021 in Serilingampally, Telangana, India. Engaging in solvent & oil extraction tech within the manufacturing sector, it holds CIN: U24110TG2021PTC151302. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹11.50 Cr and a paid-up capital of ₹11.50 Cr.
It upholds a compliant status. Its leadership includes Sridhar Raju Gadiraju (Director), Anjaneya Raju Penmetsa (Director), Nagaraju Nadimpally (Director). It holds ₹21.70 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No 301, Plot No 255, Sneha Sadan Nallagandla Serilingampally Mandal, Serilingampally, Telangana, 500019.
U24110TG2021PTC151302
151302
11 May 2021
₹11.50 Cr
₹11.50 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sahithi Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sridhar Raju Gadiraju | Director | 11 May 2021 | Current |
| Anjaneya Raju Penmetsa | Director | 11 May 2021 | Current |
| Nagaraju Nadimpally | Director | 11 May 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sahithi Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.66% increase. The company also saw a substantial fall in profitability, with a 38.01% decrease in profit. The company's net worth Soared by an impressive increase of 15.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sahithi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹217,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2025 | Axis Bank Limited | ₹4.50 M | Open |
| 22 Sep 2021 | Others | ₹8.50 Cr | Open |
| 22 Sep 2021 | Others | ₹12.75 Cr | Open |
Explore comprehensive loan charge details -
Sahithi Pharma has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sahithi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahithi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101163818 was registered on 30 Sep 2025. was recorded as a recent event.
Progress on Sahithi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Sahithi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge with Others of Rs. 8.50 Cr registered on 22 Sep 2021 with Charge ID 100486423 was modified on 29 Apr 2023. was completed.
A charge with Others amounted to Rs. 12.75 Cr with Charge ID 100486358 was registered on 22 Sep 2021. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 8.50 Cr with Charge ID 100486423 was registered on 22 Sep 2021. was documented.
The CIN of Sahithi Pharma Private Limited is U24110TG2021PTC151302.
Sahithi Pharma Private Limited is headquartered at Flat No 301, Plot No 255, Sneha Sadan Nallagandla Serilingampally Mandal, Serilingampally, Telangana, 500019.
Sahithi Pharma Private Limited was incorporated on 11 May 2021.
The current directors of Sahithi Pharma Private Limited are
The primary industry of Sahithi Pharma Private Limited is Manufacturing.
Sahithi Pharma Private Limited is unlisted.
The authorized capital of Sahithi Pharma Private Limited is ₹11.50 Cr, and the paid-up capital is ₹11.50 Cr.
The compliance status of Sahithi Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX